Simulations show VWATT to increase throughput compared to constant-weight topology-transparent schedules, to reduce both maximum and expected delay relative to schedules whose weights are not constrained to the set of weights, and to adapt rapidly to changes in topology and traffic load.
In fact, the DLMOn25% relative to bedtime and the DLMOff25% relative to scheduled waketime during the CP protocol following the 24.65-h 24.65-hark cycles were significantly later by 1 h and 42 min (P<0.01) and 1 h and 40 min (P<0.05), respecyclesy, as compared to their timing during the baseline CP protocol (Figure 2A).
Subsequently, Schedule C was added, to assess whether dose intensification, relative to Schedule B, might improve antileukaemic activity without losing the tolerability of the 2-dose schedule; two doses (72 and 90 mg/m) were evaluated for this schedule.
The phase angle of entrainment was assessed by comparing the timing of the DLMOn25% and DLMOff25% relative to the scheduled bedtime and scheduled waketime, respectively.
Intensification included a graded 10 percent increase above the standard vaccine dose or graded one-day reduction of administration interval relative to standard schedule.
The authors formally prove, under uniform random node distribution, an approximation factor for the length of the schedule relative to the shortest schedule possible under the SINR-based interference model.
Conditioning that is based on intermittent reinforcement schedules will create more powerful results relative to fixed conditioning schedules; that is, behaviour produced by intermittent reinforcement schedules is much more difficult to unlearn or discard.
Building on prior work [9], we optimize measures such as coverage relative to bandwidth and scheduling downloads of provider data.
Therefore, PNC can improve the system throughput of the three-node wireless network by a factor of 100%and50%0% relative to traditional transmission scheduling and straightforward network coding, respectively.
Identification as a schedule IV drug means that eszopiclone has accepted medical use for treatment within the United States, has a low potential for abuse in comparison to drugs in schedule III, and may lead to limited physical or psychological dependence relative to drugs in schedule III (Chapter 13 of Title 21 of the United States Code, 1970).
I don't want to see that happen, but it's worth keeping in perspective — especially when you look at the solutions "reformers" propose, which all seem to involve reducing future benefits relative to those currently scheduled.
